Semler Scientific (SMLR) – Company Press Releases
-
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
-
Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
-
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
-
Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results
-
Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023
-
Semler Scientific to Present at Upcoming Investor Conference
-
Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results
-
Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023
-
Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
-
Semler Scientific to Join the Russell 2000® and 3000® Indexes
-
Semler Scientific Reports First Quarter 2023 Financial Results
-
Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023
-
Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
-
Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors
-
Semler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference
-
Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement
-
Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results
-
Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023
-
Semler to Report Fourth Quarter and Year End 2022 Financial Results and Host Conference Call on March 21, 2023
-
Semler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting
-
Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
-
Semler Announces Investment in Monarch Medical Technologies
-
Semler Reports Third Quarter and Year-to-Date 2022 Financial Results
-
Semler to Report Third Quarter and First Nine Months of 2022 Financial Results and Host Conference Call on November 1, 2022
-
Semler Scientific to Present at Upcoming Investor Conferences
-
Semler Reports Second Quarter and First Half of 2022 Financial Results
-
Semler to Report Second Quarter and First Half 2022 Financial Results and Host Conference Call on August 2, 2022
-
Semler Reports First Quarter 2022 Financial Results
-
Semler to Report First Quarter 2022 Financial Results and Host Conference Call on May 2, 2022
-
Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference
-
Semler Scientific's Board of Directors authorizes an up to $20.0 million stock repurchase program
-
Clinical Study using QuantaFlo® published in Peer-Reviewed Journal of Vascular Surgery
-
Semler Reports Fourth Quarter and Year-to-Date 2021 Financial Results
-
Semler to Report Fourth Quarter and Year End 2021 Financial Results and Host Conference Call on February 28, 2022
-
Semler Reports Third Quarter and Year-to-Date 2021 Financial Results
-
Semler to Report Third Quarter and First Nine Months of 2021 Financial Results and Host Conference Call on November 1, 2021
-
Semler Scientific to Commence Trading on Nasdaq
-
Semler Scientific to Present at Upcoming Investor Conferences
-
Semler Reports Second Quarter and First Half of 2021 Financial Results
-
Semler to Report Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 2, 2021
-
Semler to Participate in the Raymond James Human Health Innovation Conference
-
Semler Reports First Quarter 2021 Financial Results
-
Semler to Report First Quarter 2021 Financial Results and Host Conference Call on May 3, 2021
-
Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference
-
Semler Reports Record Fourth Quarter and Year End 2020 Financial Results
-
Semler to Participate in the H.C. Wainwright Global Life Sciences Conference
-
Semler to Report Fourth Quarter and Year End 2020 Financial Results and Host Conference Call on March 1, 2021
-
Semler to Participate in the H.C. Wainwright BioConnect 2021 Conference
-
Semler Scientific Expands Board of Directors with Appointment of Policy Expert Cindy Moon
-
Semler Reports Record Third Quarter and Year-to-Date 2020 Financial Results
Back to SMLR Stock Lookup